
Kern Pharma mulls new acquisitions
Catalan Economy
26 Jun 2009
Kern pharma, a unit of pharmaceutical group indukern, has announced that it is looking into new acquisitions to grow in catalonia and strengthen its presence in international markets. indukern ceo raul diaz-varela confirmed that its company is interested in acquiring the solvay pharma plant in parets del vallès or one of labiana factories. kern facilities in terrassa could reach its maximum production capacity in less than two years, he added. the group is also studying acquisitions in france and italy to strengthen its european business. in 2008, indukern posted revenue of 550 million euros, up 7.8% over the previous year.
source: expansión catalunya 25/06/09
Related News and Success stories.
-
24 Apr 2025
5 Reasons to Choose Barcelona-Catalonia for Your Life Sciences Expansion
-
14 Apr 2025
Catalonia takes over the presidency of the Four Motors for Europe
-
09 Apr 2025
Catalonia will invest €400 million in InnoFAB, a center for advanced semiconductor development
-
07 Apr 2025
The Port of Barcelona to invest 50 million euros in the BlueTechPort, a hub for blue economy innovation